SMG
BIIB icon

Spectrum Management Group’s Biogen BIIB Stock Holding History

Spectrum Management Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8
Closed -$2K – 328
2021
Q3 		$2K Buy
+8
New +$2.62K ﹤0.01% 372
2019
Q2 		– Sell
-51
Closed -$12K – 232
2019
Q1 		$12K Buy
+51
New +$16.1K ﹤0.01% 210
2017
Q4 		– Sell
-106
Closed -$33K – 269
2017
Q3 		$33K Buy
+106
New +$31.4K 0.01% 193

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Spectrum Management Group's BIIB Position: Q4 2021 in Review

Spectrum Management Group sold out of Biogen (BIIB) in Q4 2021, closing a stake of 8 shares — an estimated $2K sold.

Spectrum Management Group first reported a position in BIIB in Q3 2017 and held it in 3 quarters. The position peaked at $33K in Q3 2017. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Spectrum Management Group reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Spectrum Management Group sold 8 Biogen shares in Q4 2021, an estimated $2K.
  • Spectrum Management Group first reported a position in Biogen in Q3 2017 and held it in 3 quarters.
  • Spectrum Management Group's Biogen position peaked at $33K in Q3 2017.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Spectrum Management Group's 13F filing for Q4 2021, filed 3 Feb 2022.